Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen
Open Access
- 28 May 2003
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 31 (11) , 981-986
- https://doi.org/10.1038/sj.bmt.1704056
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pattern and course of single‐system disease in Langerhans cell histiocytosis data from the DAL‐HX 83‐ and 90‐studyMedical and Pediatric Oncology, 2001
- FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSISHematology/Oncology Clinics of North America, 1998
- Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemiaThe Lancet, 1997
- 12-year follow-up of allogeneic bone-marrow transplant for Langerhans' cell histiocytosisThe Lancet, 1997
- HistiocytosesEuropean Journal of Pediatrics, 1995
- Treatment strategy for disseminated langerhans cell histiocytosisMedical and Pediatric Oncology, 1994
- Allogeneic bone marrow transplantation for Langerhans' cell histiocytosisCancer, 1990
- Familial hemophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 1983
- Cutaneous Histiocytosis XArchives of Dermatology, 1983
- Histiocytosis-X: In Situ Characterization of Cutaneous Infiltrates with Monoclonal AntibodiesAmerican Journal of Clinical Pathology, 1983